OlgaZhdanovaMD

Glomerular Disease

Assistant Professor, Medicine, New York University School of Medicine

Dr. Zhdanova is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

MEmbranous Nephropathy Trial Of Rituximab Start of enrollment: 2011 Nov 01
Completed
Phase 2, Phase 3

PubMed

242 citations
Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach
Crystal A. Gadegbeku, Debbie S. Gipson, Lawrence B. Holzman, Akinlolu O. Ojo, Peter X.-K. Song
Kidney International. 2013-04-01
112 citations
DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGS.
Howard Trachtman, Peter T. Nelson, Sharon G. Adler, Kirk N. Campbell, Abanti Chaudhuri
Journal of the American Society of Nephrology. 2018-11-01
90 citations
Impending Shortages of Kidney Replacement Therapy for COVID-19 Patients.
David S. Goldfarb, Judith A. Benstein, Olga Zhdanova, Elizabeth Hammer, Clay A. Block
Clinical Journal of the American Society of Nephrology. 2020-06-08

Journal Articles

DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGS
Howard Trachtman, Peter Nelson, Abanti Chaudhuri, Jai Radhakrishnan, Olga Zhdanova, Debbie S Gipson, Tarak Srivastava, Kenneth Lieberman, Vimal Kumar Derebail, Jonatha..., Journal of the American Society of Nephrology